Affiliation:
1. Novartis Institutes for BioMedical Research Inc, 22 Windsor St, Cambridge, MA 02139, USA
Abstract
Recent efforts to identify small molecules for schizophrenia with non-D2 mechanisms will be highlighted. The potential for disease modifying treatments for schizophrenia will also be discussed.
Publisher
Royal Society of Chemistry (RSC)
Subject
Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献